Study on cardioactive effects of brazilein

Pharmacology

Volumn 76, Issue 2, 2006, Pages 76-83

  Yu, Nan Zhao ^a   Pan, Yang ^a   Jia, Lin Tao ^a   Dong, Ming Xing ^a   Li, Jun Du ^a  

^a TSINGHUA UNIVERSITY   (China)

Author keywords

Brazilein; Caesalpinia sappan L.; Cardiac glycosides; Cardioactivity; Na+,K+ ATPase

Indexed keywords

6A,7 DIHYDRO 3,6A,10 TRIHYDROXYBENZ[B]INDENO[1,2 D]PYRAN 9(6H) ONE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); BETA ADRENERGIC RECEPTOR; CAESALPINIA SAPPAN EXTRACT; CARDIOTONIC AGENT; DESLANOSIDE; INOTROPIC AGENT; PROPRANOLOL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARDIOTOXICITY; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; ELECTROCARDIOGRAM; ENZYME ACTIVITY; ENZYME INHIBITION; ERYTHROCYTE; FEMALE; GUINEA PIG; HEART VENTRICLE ARRHYTHMIA; IN VIVO STUDY; INHIBITION KINETICS; INOTROPISM; ISOLATED HEART; NONHUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL;

ANIMALS; BENZOPYRANS; CAESALPINIA; CARDIOTONIC AGENTS; DRUGS, CHINESE HERBAL; ELECTROCARDIOGRAPHY; ERYTHROCYTE MEMBRANE; FEMALE; GUINEA PIGS; HEART; INDENES; MYOCARDIAL CONTRACTION; NA(+)-K(+)-EXCHANGING ATPASE; STIMULATION, CHEMICAL;

EID: 31144439752     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000089721     Document Type: Article

References (31)

1. Kim DS, Baek NI, Oh SR, Jung KY, Lee IS, Lee HK: NMR assignment of brazilein. Phytochemistry 1997;46:177-178.
2. Oliveira LFC, Edwards HGM, Velozo ES, Nesbitt M: Vibrational spectroscopic study of brazilin and brazilein, the main constituents of brazilwood from Brazil. Vib Spectrosc 2002;228:243-249.
3. Xu ZX, Yan YJ: A supplementary report on pharmacology of Caesalpinia sappan. Chin Med J 1955;5:568-573.
4. Xu ZX, Yan YJ: Studies on pharmacology of Caesalpinia sappan. Chin Med J 1956;6:568-573.
5. Baek NI, Jeon SG, Ahn EM, Hahn JT, Bahn JH, Jang JS, Cho SW, Park JK, Choi SY: Anticonvulsant compounds from the wood of Caesalpinia sappan L. Arch Pharm Res 2000;23:344-348.
6. Oh SY, Kim DS, Lee IS, Jung KY, Lee JJ, Lee H: Anticomplementary activity of constituents from the heartwood of Caesalpinia sappan. Planta Med 1998;64:456-458.
7. Shih IM, Chiang HS, Yang LL, Wang TL: Antimotility effects of Chinese herbal medicines on human sperm. J Formos Med Assoc 1990;89:466-469.
8. Zheng MS, Zhang YZ: Anti-HBsAg herbs employing ELISA technique. J Mod Dev Tradit Med 1990;10:560-562.
9. Walsh V, Goodman J: Cancer chemotherapy, biodiversity, public and private property: the case of the anti-cancer drug Taxol. Soc Sci Med 1999;49:1215-1225.
10. Li M, Handa S, Ikeda Y, Goto S: Specific inhibiting characteristics of tetramethylpyrazine, one of the active ingredients of the Chinese herbal medicine 'Chuanxiong' on platelet thrombus formation under high shear rates. Thromb Res 2001;104:15-28.
11. Meshnick SR: Artemisinin: mechanisms of action, resistance and toxicity. Int J Parasit 2002;32:1655-1660.
12. Yan XL, Wang W, Xing DM, Zhao YN, Du LJ: Development and optimization of a method for the analysis of brazilein by HPLC with electrochemical detection. J Chromatogr A 2005;1007:44-48.
13. Han H, Hoffmann S, Hu K, Ertl G: Angiotensin II subtype 1 (AT1) receptors contribute to ischemic contracture and regulate chemomechanical energy transduction in isolated transgenic rat (aMHC-Hat1) 594-17 hearts. Eur J Heart Fail 2002;4:131-137.
14. Eder K, Reichimayr-Lais AM, Kirchgessner M: Studies on the determination of Na-K-ATPase in red blood cell membranes. J Trace Elem Electrolytes Health Dis 1989;3:151-159.
15. Lowry OH, Rosebrough NJ, Farr AL, Randal RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275.
16. 2+-ATPaSe activities and biogenic amine concentrations in phenylketonuria. Clin Biochem 2002;35:281-285.
17. Sudo J, Terui J, Iwase H, Kakuno K: Assay of ATPase and Na,K-ATPase activity using high-performance liquid chromatographic determination of ADP derived from ATP. J Chromatogr B 2000;744:19-23.
18. +-ATPase inhibition by cardiac glycosides with fast and low binding kinetics. Eur J Pharmacol 1997;335:89-97.
19. Kalyoncu NI, Ozyavuz R: Ketanserin inhibits digoxin-induced arrhythmias in the anaesthetized guinea-pig. Fundam Clin Pharmacol 1999;13:646-649.
20. Small A, McElroy HW, Ide RS: Studies of the electrocardiogram and the toxicity of cardiac glycosides in animals exposed to hyperbaric helium. Toxicol Appl Pharmacol 1971;20:44-56.
21. Weinhouse E, Kaplanski J, Posner J: Comparison of digoxin-induced cardiac toxicity in resistant and sensitive species. J Pharm Pharmacol 1983;35:580-583.
22. Bakke OM, Aslaksen A, Lehmann V, Lien E: Pharmacokinetics and serum concentration-effect relationship of intravenous deslanoside. J Cardiovasc Pharmacol 1981;3:1015-1025.
23. Fricke U: New aspects on the mode of action of cardiac glycosides. Fortschr Med 1976;94:1037-1045.
24. +-ATPaSe. Eur J Pharmacol 2000;400:177-183.
25. +-ATPaSe activity. Biochem Biophys Res Commun 1997;235:374-376.
26. Helms JB, Amett KL, Gatto C, Milanick MA: Bretylium, an organic quaternary amine, inhibits the Na,K-ATPase by binding to the extracellular K-site. Blood Cells Mol Dis 2004;32:394-400.
27. +-ATPase. J Biol Chem 1994;269:19659-19662.
28. Schwinger RHG, Bundgaard, Muller-Ehrnsen J, Kjeldsen K: The Na,K-ATPase in the failing human heart. Cardiovasc Res 2003;57:913-920.
29. Schwartz A, Lindenmayer GE, Allen JC: The sodium-potassium adenosine triphosphatase: pharmacological physiological and biochemical aspects. Pharmacol Rev 1975;27:3-134.
30. +-ATPase. Eur J Pharmacol 1985;111:147-157.
31. +-ATPase from Guinea pig and rat hearts. Braz J Med Biol Res 1989;22:433-445.